Fluticasone Propionate Multidose Dry Powder Inhaler and Fluticasone Propionate/Salmeterol in Patients with Asthma
- Study Title
- Long-Term Safety Study of Fluticasone Propionate (Fp) Multidose Dry Powder Inhaler (MDPI) and Fluticasone Propionate/Salmeterol (FS) MDPI in Patients With Persistent Asthma
- Teva Identifier
- FSS-AS-305
- ClinicalTrials.gov Identifier
- NCT02175771
- Study Status
- Completed
- Trial Condition(s)
- Persistent Asthma
- Interventions
- Drug: Fp MDPI | Drug: FS MDPI | Drug: FLOVENT HFA | Drug: ADVAIR DISKUS | Drug: albuterol/salbutamol HFA
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Child, Adult, Older Adult
- Age Range
- 12 Years and older
- Trial Duration
- 07/01/2014 - 07/01/2015
- Phase
- Phase 3